Literature DB >> 20663408

Quantification of the galactose-operon mRNAs 5 bases different in their 5'-ends.

Sang Chun Ji1, Xun Wang, Heung Jin Jeon, Sang Hoon Yun, Hee Jung Lee, Heon M Lim.   

Abstract

Three assay methods for quantification of the two galactoseoperon mRNAs that only differ by 5 bases in their 5'-end are presented. The 5' ends of each mRNA were extended by ligating the 3'-end of the abundant 5S rRNA. This ligation extends the 5' ends of the two gal mRNAs long enough to be distinguished by the specific PCR primers in the following quantification reactions. Quantification of the corresponding cDNAs was performed either by primer extension assay or real-time qPCR. To circumvent the problem of the RNA ligation reaction (i.e. very low ligation efficiency), we devised a new method that employs real-time qPCR directly for the quantification of the gal transcripts which differ by 5 bases in their 5'-ends.

Mesh:

Substances:

Year:  2010        PMID: 20663408     DOI: 10.5483/bmbrep.2010.43.7.474

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  3 in total

1.  Two-level inhibition of galK expression by Spot 42: Degradation of mRNA mK2 and enhanced transcription termination before the galK gene.

Authors:  Xun Wang; Sang Chun Ji; Heung Jin Jeon; Yonho Lee; Heon M Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-04       Impact factor: 11.205

2.  The CnuK9E H-NS complex antagonizes DNA binding of DicA and leads to temperature-dependent filamentous growth in E. coli.

Authors:  Sang Hoon Yun; Sang Chun Ji; Heung Jin Jeon; Xun Wang; Si Wouk Kim; Geunu Bak; Younghoon Lee; Heon M Lim
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

3.  In vivo transcription dynamics of the galactose operon: a study on the promoter transition from P1 to P2 at onset of stationary phase.

Authors:  Sang Chun Ji; Xun Wang; Sang Hoon Yun; Heung Jin Jeon; Hee Jung Lee; Hackjin Kim; Heon M Lim
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.